Compare COCH & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | COCH | OCCI |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9M | 44.6M |
| IPO Year | 2021 | 2017 |
| Metric | COCH | OCCI |
|---|---|---|
| Price | $6.26 | $1.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.67 | N/A |
| AVG Volume (30 Days) | 12.7K | ★ 262.2K |
| Earning Date | 11-05-2026 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | ★ 17.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $241,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.14 | $10.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.11 | N/A |
| 52 Week Low | $5.36 | $1.40 |
| 52 Week High | $66.06 | $5.15 |
| Indicator | COCH | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 26.74 |
| Support Level | $5.36 | $1.40 |
| Resistance Level | $40.14 | $2.68 |
| Average True Range (ATR) | 1.89 | 0.11 |
| MACD | -0.42 | -0.00 |
| Stochastic Oscillator | 2.08 | 22.45 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.